U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...

CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

If approved, AbbVie's Rinvoq could be set to dominate the alopecia market after exhibiting better efficacy than main ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

According to a report by the Financial Times, Morgan & Morgan, a law firm, revealed it had filed a case on behalf of a ...

Sales of the weight loss injection Wegovy have skyrocketed in the UK after the manufacturer of rival drug Mounjaro announced ...

A paean is “a fervent expression of joy or praise.” When it comes to the long and ongoing struggle to preserve the incredible ...

Eli Lilly and Company faces a pivotal period with the upcoming retirement of Anne White, a key neuroscience leader set for ...

J&J said on Thursday it has reached a 10-year agreement with Tokyo-based contract drug developer Fujifilm Biotechnologies for ...

With the cost of the weight-loss jab set to rise by up to 170 per cent, Jade Kay, who has already spent £2,400 on the drug, says she will take a second job waitressing if she has to ...